Cardiac and vascular tissue combined represent 44% of total sales. This is a ZERO “net operating income” Gerbil Factory as best I can determine. DAL cryptically said as much late during the CC. Chalk this 44% of revenues up as a BIG FAT LOSER WITH A LIABILITY TAIL. Anybody on this message board ever heard of Brian Lykins?
Poorhouse, this stock price is still in the #$%$ house". As poorhouse said in his post, CRY is always a few quarters (and perhaps a few Stevie Wonder stories) away from where they are telling shareholders they are going. Remember three years ago? The analyst’s then were projecting EPS double what they are projecting now. As I recall, CRY was a $5-$6 dollar stock in 1996. It still is a $5-$6 stock now. Perhaps there is a reason. Perhaps management has some issues. I’m just guessing of course.